CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment

---
identifier: "/us/fr/2011-27770"
source: "fr"
legal_status: "authoritative_unofficial"
title: "CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment"
title_number: 0
title_name: "Federal Register"
section_number: "2011-27770"
section_name: "CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment"
positive_law: false
currency: "2011-10-27"
last_updated: "2011-10-27"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2011-27770"
document_type: "notice"
publication_date: "2011-10-27"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "76 FR 66721"
fr_volume: 76
---


#  CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment

In accordance with section l0(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) announce the following committee meeting.

*Times and Dates:* 8 a.m.-5:30 p.m., November 15, 2011. 8 a.m.-3 p.m., November 16, 2011.

*Place:* The Legacy Hotel and Meeting Centre, 1775 Rockville Pike, Rockville, Maryland 20852, Telephone: (301) 881-2300.

*Status:* Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people.

*Purpose:* This Committee is charged with advising the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/AIDS and other STDs, the support of health care services to persons living with HIV/AIDS, and education of health professionals and the public about HIV/AIDS and other STDs.

*Matters To Be Discussed:* Agenda items include: (1) National HIV/AIDS Strategy Implementation Update; (2) CHAC Workgroups Update; (3) Review and Response to the Urgent Threat of Gonorrhea Antimicrobial Resistance; (4) CDC Division of Adolescent School Health Overview; and (5) Recent HIV Prevention Trials Network Studies.

Agenda items are subject to change as priorities dictate.

*Contact Person for More Information:* Margie Scott-Cseh, CDC, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333, Telephone: (404) 639-8317.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: October 20, 2011.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).